✦ LIBER ✦

Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer

✍ Scribed by Cristina Grávalos; Carlos Gómez-Martín; Fernando Rivera; Inmaculada Alés; Bernardo Queralt; Antonia Márquez; Ulpiano Jiménez; Vicente Alonso; Rocío García-Carbonero; Javier Sastre; Ramon Colomer; Hernán Cortés-Funes; Antonio Jimeno

Book ID: 107597774
Publisher: Springer Milan
Year: 2011
Tongue: Spanish
Weight: 424 KB
Volume: 13
Category: Article
ISSN: 1699-048X
DOI: 10.1007/s12094-011-0637-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of trastuzumab in Japanese pati

Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study

✍ Sawaki, Akira; Ohashi, Yasuo; Omuro, Yasushi; Satoh, Taroh; Hamamoto, Yasuo; Bok 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 268 KB

Trastuzumab plus docetaxel with or witho

Trastuzumab plus docetaxel with or without capecitabine as first-line therapy for HER2-positive locally advanced or metastatic breast cancer: a randomised Phase II study

✍ A. Wardlev; A. Anton-Torres; X. Pivot; F. Morales-Vasquez; L. Zetina; M. de Fati 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Phase II study of trastuzumab in combina

Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1)

✍ Kurokawa, Y; Sugimoto, N; Miwa, H; Tsuda, M; Nishina, S; Okuda, H; Imamura, H; G 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 464 KB

CPT-11 plus cisplatin in patients with a

CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma : Results of a Phase II study

✍ Jaffer A. Ajani; Jackie Baker; Peter W. T. Pisters; Linus Ho; Paul F. Mansfield; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

Randomized Phase II Trial of weekly pacl

Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer

✍ Giampietro Gasparini; Massimo Gion; Luigi Mariani; Paola Papaldo; Diana Crivella 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 222 KB

Pharmacokinetic analysis of capecitabine

Pharmacokinetic analysis of capecitabine and cisplatin in combination with trastuzumab in Japanese patients with advanced HER2-positive gastric cancer

✍ Taroh Satoh; Yasushi Omuro; Yasutsuna Sasaki; Yasuo Hamamoto; Narikazu Boku; Tak 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 227 KB